SUBSCRIBE

Breaking News on Supplements & Nutrition - EuropeUS edition

On your radar > Financial plays

Financial plays

Financial plays

Digging below the bottom lines of ingredients suppliers and brand behemoths. From the impact of the ongoing economic slowdown to the latest in merger and acquisition activity.

Solvay management buys out Solactis

€13bn Belgian supplier Solvay has sold its Solactis nutrition division that includes galactofructose  (lactulose) to its former nutrition programme manager.

Tate & Lyle meeting profit targets despite 4% US soft drink slide

Tate & Lyle CEO Javed Ahmed says earning and profit forecasts are intact – “mid single digit growth” – despite an unseasonably cold spring that has contributed to an annual drop of...

Irish microbiota research centre to receive €50m boost

The Alimentary Pharmabiotic Centre (APC) in Cork, Ireland has received a €36m investment from the Irish government that will fund its research activities for at least another six years, its...

Provexis seeks to demerge Science in Sport and Fruitflow

UK firm Provexis has filed to demerge the Science in Sport (SiS) consumer sports brand it purchased for €10m in June 2011 from its Fruitflow tomato-based ingredients business, as it...

Bioseutica sells high-end omega-3 division to German equity firm; major expansion planned

Swiss nutra and pharma ingredient player Bioseutica has sold 85% of its KD Pharma high-end omega-3 business to German equity firm Capiton. Serious expansion is planned.

Exclusive interview

Naturex CEO talks HQ expansion, green credentials and the memory of Jacques Dikansky

Naturex hosted 500 of its employees and guests the weekend just passed as it inaugurated a €12m expansion of its Avignon HQ in southern France. We caught up with CEO...

DSM Q1 sales steady; happy with acquisitions

Strong nutrition sales drove a steady quarter at DSM with sales up 10% in that division, as EBITDA profits improved €5m across the company to €311m compared to €306m in Q1 2012.

Q1 2013: Naturex net profit up 67%

Naturex has seen sales rise 13.2% to €83.2m in Q1 2013, with Nutrition its star core business performer, leaping about 33% from €22m to just over €29m.

GSK's iconic tonic: Abandon Ribena and Lucozade to Big Beverage

GlaxoSmithKline will sell its “iconic brands” Lucozade and Ribena to a beverage giant – if the price is right – the company announced in its Q1 results yesterday.

Symrise wins €125m EIB loan for nutrition and skin R&D

Cosmetics and nutrition are the focal points for a €125m research and development loan gained by supplier Symrise.

Danone results get Asia baby food boost

Danone reported sales growth in the first quarter of 2013 as demand for baby food in Asia boosted profits, despite continued weakness in Europe.

South Korean OK for BASF's Scottish Omega-3 plant

South Korean regulators have cleared BASF to produce pharmaceutical grade omega-3 at its facility in Scotland.

Soy industry: FAO protein findings only useful in malnourished populations

The European soy sector says a UN report that found dairy proteins offer a superior amino acid profile to plant proteins is only meaningful for the malnourished.

a2 Milk UK establishment costs offset A2 Corporation H1 sales increase

Costs relating to the establishment of the a2 Milk UK joint venture contributed to a H1 profits decrease for Australasian dairy processor A2 Corporation (A2C), the company has revealed.

Central European food supplements market hit €1bn for first time

Food supplement markets in Poland, the Czech Republic, Romania, Hungary, Bulgaria and Slovakia have pushed through the €1bn mark for the first time, with Romania starring with 24% growth in...

Raisio sells €7m oat, soy and rice business to Norwegian firm

Finnish ag-food giant Raisio has sold its €7m a year oat, soy and rice foods business that includes its Soygurt business to €330m Norwegian food company Kavli.

Nestlé buys Louisiana depression food firm

Nestlé has bought its second brain health-focused medical foods start-up in eight months after snaffling Red River Pharma-owned Pamlab which makes high-dose vitamin supplements targeting depression, diabetes and Alzheimer’s.

Forté Pharma sales up 1.5% in 2012

2012 sales have risen 1.5% at Forté Pharma, the food supplements arm of Spanish player Natraceutical, with weight management products dominating.

Special edition: Omega-3 (Editor's blog)

How high can high-end omega-3 go?

Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted...

UK venture capitalists eye expansion at Israeli antioxidant specialists

Southern Israel-based algae-sourced astanxanthin specialists Algatechnologies has won investment from a UK venture capitalist in a move that will broaden its capacity, R&D and distribution scope for the eye and...

M&A numbers down, but value of deals is up, investment group says

Nutrition Capital Network noted a record 247 deals in the health and wellness sector in 2012.  Within that number, the group noted a decline in the number of M&A deals...

Acquisition happy: Naturex 2012 sales up 18.1% in 2012 ; Raisio improves 5.7%

Two leading European ingredients suppliers have bucked hard economic times to post strong results for 2012, with French botanical extracts specialist, Naturex, and Finish agriculture, ingredients and brand owner, Raisio,...

Probi 2012 sales up 6%, but ProViva royalties set for dive

The European probiotic sector is bracing itself for tough times ahead in the wake of December’s  EU health claim ban for the sector, but the effects are yet to be...

EDITOR'S OPINION: DEAR DAIRY....

Chobani’s global ambitions: Too much, too young?

At just seven years old, Chobani is a poster boy in the eyes of some, a market-devouring monster in the eyes of others. The New York-based Greek yogurt giant’s expansion...

BASF ups offer for omega-3 API maker Pronova

BASF has increased its cash offer for omega-3 API maker Pronova Biopharma to €684m.